Logo-jcvtr
Submitted: 09 Mar 2021
Accepted: 08 Jul 2021
ePublished: 11 Aug 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Cardiovasc Thorac Res. 2021;13(3): 203-207.
doi: 10.34172/jcvtr.2021.36
  Abstract View: 242
  PDF Download: 264
  Full Text View: 54

Original Article

The incidence of myopericarditis in patients with COVID-19

Atoosa Mostafavi 1 ORCID logo, Seyed Abdol Hussein Tabatabaei 1* ORCID logo, Somayeh Zamani Fard 1, Fatemeh Majidi 1, Abbas Mohagheghi 1, Shahin Shirani 1

1 Department of Cardiology, Tehran University of Medical Science, Dr Ali Shariati Hospital, Tehran, Iran
*Corresponding Author: Seyed Abdol Hussein Tabatabaei, Email: tabatabaeiseyedah@gmail.com

Abstract

Introduction: SARS-COV-2 can affect different organ systems, including the cardiovascular system with wide spectrum of clinical presentations including the thrombotic complications, acute cardiovascular injury and myopericarditis. There is limited study regarding COVID-19 and myopericarditis. The aim of this study was to evaluate myopericarditis in patients with definite diagnosis of COVID-19.
Methods: In this observational study we analyzed the admitted patients with definite diagnosis of COVID-19 based on positive RT-PCR test. Laboratory data, and ECG changes on days 1-3-5 were analyzed for sign of pericarditis and also QT interval prolongation. Echocardiography was performed on days 2-4 and repeated as necessary, and one month after discharge for possible late presentation of symptom. Any patient with pleuritic chest pain, and pericardial effusion and some rise in cardiac troponin were considered as myopericarditis.
Results: A total of 404 patients (18-90 years old, median =63, 273 males and 131 females) with definite diagnosis of COVID-19 were enrolled in the study. Five patients developed in-hospital pleuritic chest pain with mild left ventricular dysfunction and mild pericardial effusion and diagnosed as myopericarditis, none of them proceed to cardiac tamponade. We found no case of late myopericarditis.
Conclusion: Myopericarditis, pericardial effusion and cardiac tamponade are rare complication of COVID-19 with prevalence about 1.2 %, but should be considered as a possible cause of hemodynamic deterioration.

Keywords: Pericarditis, Pericardial Effusion, Myocarditis, Myopericarditis, COVID-19, SARS-COV-2

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 243

Your browser does not support the canvas element.


PDF Download: 264

Your browser does not support the canvas element.


Full Text View: 54

Your browser does not support the canvas element.